Allergan plc·4

Apr 5, 7:01 PM ET

Nicholson C. David 4

4 · Allergan plc · Filed Apr 5, 2018

Insider Transaction Report

Form 4
Period: 2018-04-03
Nicholson C. David
Chief R&D Officer
Transactions
  • Tax Payment

    Ordinary Shares, par value $0.0001

    2018-04-03$164.74/sh871$143,48917,357 total
Footnotes (1)
  • [F1]Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.

Documents

2 files
  • 4
    nicholsonf4.xmlPrimary

    OWNERSHIP DOCUMENT

  • EX-24

    SECTION 16 POWER OF ATTORNEY